Ttm purpose of this study was to evaluate whether nedocromil sodium benefits urban asthmatic children showing seasonal bronchial hyper-reactivity to ultrasonic nebulization of distilled water (UNDW). A prospective, randomized, placebo-controlled, parallel-group, double-blind study was carried out at the outpatient pulmonology service at a tertiary-care teaching hospital.
Introduction
Bronchial hyper-reactivity (i.e. exaggerated bronchoconstrictive response to various stimuli) is a characteristic of asthma both in children and adults. 1," Bronchial hyper-reactivity is, in part, genetically determined and, in part, a consequence of airway inflammation, and it is closely related to the severity of the disease. Studies performed on animal models show that exposure to such environmental pollutants as SO4 and ozone may induce bronchial hyper-reactivity, and it has been suggested that climate-therapy may attenuate these effects. 9, 1 In children living in urban areas, exposure to pollution has been associated with an increase in the number of cases of secretive chronic bronchitis and to a reduction in respiratory function, 11 as well as to an increase in asthma 1" and to a higher risk of allergic sensitization.
Anti-inflammatory drugs, such as inhaled corticosteroids and cromones, are widely used to reverse bronchial hyper-reactivity. 14 (Table 4) . FEF 25-75 changes after UNDW, which were initially comparable, showed a progressive decrease in bronchoreactivity in group N, and no change in group P (Table 5 ).
Discussion
Although changes in bronchial reactivity have been reported in adult and young asthmatic patients, few attempts have been made to identiy the cause of this behaviour. In allergic children, bronchial reactivity may increase during the season of exposure to the allergen. 14, 15 Children affected by episodic asthma or by seasonal, non-atopic, recurrent asthma, whose hyper-reactivity was seasonal (i.e. it appeared in winter and disappeared in summer) were studied. In these cases, alteration in reactivity may reflect an inflammatory process induced, in winter, by such '6 and prevents infiltration of neutrophils from bronchial mucosa of dogs exposed to ozone. 8 Recent findings suggest that nedocromil sodium downregulates activation of cells involved in the latephase asthmatic reaction, such as eosinophils, '7 mastcells and T-cells. 28 Although it inhibits the development of mucosal inflammation, it was uncertain whether nedocromil sodium eliminates or reduces existing inflammatory changes. '9 Our data suggest that it can do this, as clinical trials have demonstrated its efficacy in diminishing the late phase asthmatic reaction. Therefore, the drug not only prevents the seasonal increase in aspecific bronchial reactivity as previously reported in patients naturally exposed to allergens, 15, 16 but it is also useful in the treatment of non-allergic asthma.
In conclusion, nedocromil sodium, which may be used as prophylaxis in atopic asthmatic subjects with symptoms and bronchial hyper-reactivity upon natural exposure to allergens, may also be used to treat children suffering from episodic asthma, in whom airway inflammation increases bronchial reactivity.
